Covid-19 man­u­fac­tur­ing roundup: Con­struc­tion un­der­way on Mo­roc­co's $562M vac­cine plant; Ar­genti­na be­gins Sput­nik pro­duc­tion

The vac­cine man­u­fac­tur­ing site worth a half-a-bil­lion dol­lars set to go up in Mo­roc­co is now un­der con­struc­tion.

Sen­syo Phar­mat­e­ch’s site worth $562 mil­lion in Bensli­mane was in­au­gu­rat­ed at the end of Jan­u­ary in a cer­e­mo­ny at­tend­ed by King Mo­hammed VI. The fill-fin­ish site is a joint col­lab­o­ra­tion be­tween the Mo­roc­can gov­ern­ment, which is cov­er­ing the en­tire cost of the plan, and Swedish phar­ma Re­ci­pharm. The site is in­tend­ed to build up mR­NA vac­cine ca­pac­i­ty in the coun­try over the next five years, and end re­liance on im­port­ed vac­cines.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.